Cleerly ISCHEMIA vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Cleerly ISCHEMIA is designed for non-invasive diagnosis and treatment planning of coronary artery disease using CCTA scans. In contrast, IM007 is a remote monitoring platform that aggregates data from cardiac implantable electronic devices to streamline patient management and reduce alerts. Therefore, they serve different stages of cardiac care, with Cleerly focusing on initial diagnostic assessment and IM007 on ongoing patient monitoring.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. IM007 is an FDA-cleared, AI-powered, cloud-based platform for remote cardiac monitoring, aggregating data from all cardiac implantable electronic devices (CIEDs) to streamline workflows, reduce false alerts, and improve patient outcomes in cardiology and heart failure management.
Cleerly ISCHEMIA analyzes data from CCTA scans to assess coronary plaque characteristics, stenosis severity, and estimate fractional flow reserve (FFR). IM007 aggregates and analyzes data from various cardiac implantable electronic devices (CIEDs) from manufacturers like Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
Cleerly ISCHEMIA's AI focuses on CCTA analysis for non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization (volume, type, location), and stenosis severity assessment. IM007's AI is centered on managing remote cardiac monitoring data, including AI-driven alert management to reduce false positives (e.g., 79% for ILR ECG Analyzer, 85% for AF alerts) and predictive AI like SignalHF for heart failure hospitalization risk.
Yes, Cleerly ISCHEMIA offers integration with PowerScribe via API. IM007 provides EHR integration capabilities through a bidirectional API and an integration framework.
Cleerly ISCHEMIA is designed for Cardiology and Radiology specialties. IM007 is intended for Cardiology and Hospital Medicine, focusing on remote cardiac monitoring and heart failure management.
More Comparisons
Backers
Who funded each tool's parent company.